Cutaneous blood flow in dermatomyositis and its association with disease severity

Skin Research and Technology

Volumn 13, Issue 3, 2007, Pages 285-292

  Dawn, Aerlyn ^a   Thevarajah, Suganthi ^a,b   Cayce, Kimberly A ^a   Carroll, Christie L ^a   Duque, Maria L ^a   Chan, Yiong Huak ^c   Jorizzo, Joseph L ^a   Yosipovitch, Gil ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b HOSPITAL KUALA LUMPUR   (Malaysia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Amyopathic dermatomyositis; Dermatomyositis; Laser doppler perfusion imager; Skin blood flow

Indexed keywords

DERMATOMYOSITIS; LASER DOPPLER PERFUSION IMAGER; SKIN BLOD FLOW;

BLOOD; CORRELATION METHODS; DERMATITIS; FLOW MEASUREMENT; LASER APPLICATIONS; MEDICAL IMAGING; SKIN;

DERMATOLOGY;

CREATINE KINASE; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DERMATOMYOSITIS; DISEASE COURSE; DISEASE SEVERITY; ERYTHEMA; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; MALE; SCORING SYSTEM; SKIN BLOOD FLOW; SKIN SURFACE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; DERMATOMYOSITIS; FEMALE; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGIONAL BLOOD FLOW; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 34447260493     PISSN: 0909752X     EISSN: 16000846     Source Type: Journal    
DOI: 10.1111/j.1600-0846.2007.00226.x     Document Type: Article

References (44)

1. Benbassat J, Geffel D, Zlotnick A. Epidemiology of polymyositis-dermatomyositis in Israel, 1960-76. Israel J Med Sci 1980; 16: 197-200.
2. Oddis CV, Conte CG, Steen VD et al. Incidence of polymyositis-dermatomyositis: A 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990; 17: 1329-1334.
3. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-347.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-407.
5. Ganczarczyk ML, Lee P, Armstrong SK. Nailfold capillary microscopy in polymyositis and dermatomyositis. Arthritis Rheum 1988; 31: 116-119.
6. Maricq HR, Spencer-Green G, LeRoy EC. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med 1976; 61: 862-870.
7. Redisch W, Messina EJ, Hughes G et al. Capillaroscopic observations in rheumatic diseases. Ann Rheum Dis 1970; 29: 244-253.
8. Bergman R, Sharony L, Schapira D et al. The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 2003; 139: 1027-1030.
9. Maricq HR. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma. Arch Dermatol 1992; 128: 630-632.
10. Wang SJ, Lin WY, Hsu CY et al. Xe-133 muscle blood flow in polymyositis and dermatomyositis. Gaoxiong. Yi Xue Ke Xue Za Zhi 1993; 9: 454-459.
11. van Beekvelt MC, Wevers RA, van Engelen BG et al. Muscle tissue oxygenation as a functional tool in the follow up of dermatomyositis. J Neurol Neurosurg Psychiatry 2002; 73: 93-94.
12. Eun HC. Evaluation of skin blood flow by laser Doppler flowmetry. Clin Dermatol 1995; 13: 337-347.
13. Obeid AN, Barnett NJ, Dougherty G et al. A critical review of laser Doppler flowmetry. J Med Eng Technol 1990; 14: 178-181.
14. Ferrell WR, Sturrock RD, Mallik AK et al. Laser Doppler perfusion imaging of proximal interphalangeal joints in patients with rheumatoid arthritis. Clin Exp Rheumatol 1996; 14: 649-652.
15. Meyer MF, Czaplewski H, Braun J et al. Lack of a difference in increased capillary blood cell velocity in the skin over proximal interphalangeal joints between rheumatoid arthritis and osteoarthritis. Microvasc Res 2005; 70: 1-6.
16. Ng EY, Fok SC, Goh CT. Case studies of laser Doppler imaging system for clinical diagnosis applications and management. J Med Eng Technol 2003; 27: 200-206.
17. Murray AK, Herrick AL, Moore TL et al. Dual wavelength (532 and 633nm) laser Doppler imaging of plaque psoriasis. Br J Dermatol 2005; 152: 1182-1186.
18. Yosipovitch G, Chan YH, Tay YK et al. Thermosensory abnormalities and blood flow dysfunction in psoriatic skin. Br J Dermatol 2003; 149: 492-497.
19. Dawkins MA, Jorizzo JL, Walker FO et al. Dermatomyositis: A dermatology-based case series. J Am Acad Dermatol 1998; 38: 397-404.
20. Sontheimer RD. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol 1999; 11: 475-482.
21. Faust HB, Gonin R, Chuang TY et al. Reliability testing of the dermatology index of disease severity (DIDS). An index for staging the severity of cutaneous inflammatory disease. Arch Dermatol 1997; 133: 1443-1448.
22. Kikuchi K, Kubo M, Kadono T et al. Serum concentrations of vascular endothelial growth factor in collagen diseases. Br J Dermatol 1998; 139: 1049-1051.
23. Kadono T, Kikuchi K, Kubo M et al. Serum concentrations of basic fibroblast growth factor in collagen diseases. J Am Acad Dermatol 1996; 35: 392-397.
24. Wanchu A, Khullar M, Sud A et al. Nitric oxide production is increased in patients with inflammatory myositis. Nitric Oxide 1999; 3: 454-458.
25. Wanchu A, Khullar M, Deodhar SD et al. Nitric oxide synthesis is increased in patients with systemic lupus erythematosus. Rheumatol Int 1998; 18: 41-43.
26. Feldman D, Hochberg MC, Zizic TM et al. Cutaneous vasculitis in adult polymyositis/dermatomyositis. J Rheumatol 1983; 10: 85-89.
27. Chwalinska-Sadowska H, Maldykowa H. Polymyositis-dermatomyositis - a 25-year follow-up of 50 patients (analysis of clinical symptoms and signs and results of laboratory tests). Mater Med Pol 1990; 22: 205-212.
28. Ohno A, Mitsui T, Endo I et al. Dermatomyositis associated with Sjogren's syndrome: VEGF involvement in vasculitis. Clin Neuropathol 2004; 23: 178-182.
29. Matsui N, Mitsui T, Endo I et al. Dermatomyositis with peripheral nervous system involvement: Activation of vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) in vasculitic lesions. Intern Med 2003; 42: 1233-1239.
30. Sibenge S, Gawkrodger DJ. Rosacea: A study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol 1992; 26: 590-593.
31. Bongard O, Miescher PA, Bounameaux H. Altered skin microcirculation in patients with systemic lupus erythematosus. Int J Microcirc Clin Exp 1997; 17: 184-189.
32. Cosnes A, Amaudric F, Gherardi R et al. Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids. Arch Dermatol 1995; 131: 1381-1385.
33. Callen JP, Jorizzo JL. Amyopathic dermatomyositis (dermatomyositis sine myositis). J Am Acad Dermatol 1992; 26: 505-506.
34. Ang P, Sugeng MW, Chua SH. Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: A 3-year retrospective review of their clinical characteristics and association with malignancy. Ann Acad Med Singapore 2000; 29: 219-223.
35. Chang CJ, Hou KH. High-resolution optical Doppler tomography for in vitro and in vivo fluid flow dynamics. Chang Gung Med J 2003; 26: 403-411.
36. Nelson JS, Kelly KM, Zhao Y et al. Imaging blood flow in human port-wine stain in situ and in real time using optical Doppler tomography. Arch Dermatol 2001; 137: 741-744.
37. Bircher A, de Boer EM, Agner T et al. Guidelines for measurement of cutaneous blood flow by laser Doppler flowmetry. A report from the standardization group of the European society of contact dermatitis. Contact Dermatitis 1994; 30: 65-72.
38. de Boer EM, Bezemer PD, Bruynzeel DP. A standard method for repeated recording of skin blood flow using laser Doppler flowmetry. Derm Beruf Umwelt 1989; 37: 58-62.
39. Berardesca E, Maibach HI. Sodium-lauryl-sulphate-induced cutaneous irritation. Comparison of white and Hispanic subjects. Contact Dermatitis 1988; 19: 136-140.
40. Berardesca E, Maibach HI. Racial differences in sodium lauryl sulphate induced cutaneous irritation: Black and white. Contact Dermatitis 1988; 18: 65-70.
41. Petersen LJ, Kristensen JK. Topical corticosteroid inhibits autoregulation of cutaneous blood flow. Scand J Clin Lab Invest 1989; 49: 189-193.
42. Petersen LJ, Kristensen JK. Time-course of corticosteroid-induced blood flow reduction in normal cutaneous tissue -quantitative measurements during 72h of treatment. Clin Exp Dermatol 1989; 14: 210-213.
43. Kristensen JK, Wadskov S. Studies on 133Xe wash-out from human skin: quantitative measurements of blood flow in normal and corticosteroid-treated skin. J Invest Dermatol 1977; 68: 196-200.
44. Yosipovitch G, Sackett-Lundeen L, Goon A et al. Circadian and ultradian (12h) variations of skin blood flow and barrier function in non-irritated and irritated skin-effect of topical corticosteroids. J Invest Dermatol 2004; 122: 824-829.